The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of low-molecular-weight heparins.
Ammollo
Concetta T
CT
Semeraro
Fabrizio
F
Semeraro
Nicola
N
Colucci
Mario
M
D025901:Carboxypeptidase B2 / Q000097:blood; D004305:Dose-Response Relationship, Drug; D015951:Factor Xa / Q000378:metabolism; D065427:Factor Xa Inhibitors; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D010446:Peptide Fragments / Q000097:blood; D011516:Prothrombin / Q000037:antagonists & inhibitors* / Q000378:metabolism; D013925:Thromboplastin / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000097:blood
D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010446:Peptide Fragments; C045879:prothrombin fragment 1.2; D011516:Prothrombin; C025337:Factor IIa; D013925:Thromboplastin; D025901:Carboxypeptidase B2; D015951:Factor Xa; D010959:Tissue Plasminogen Activator